Plasma Diamine Oxidase Activity Is a Useful Biomarker for Evaluating Gastrointestinal Tract Toxicities during Chemotherapy with Oral Fluorouracil Anti-Cancer Drugs in Patients with Gastric Cancer

Oncology

Volumn 82, Issue 3, 2012, Pages 147-152

  Namikawa, Tsutomu ^a   Fukudome, Ian ^a   Kitagawa, Hiroyuki ^a   Okabayashi, Takehiro ^a   Kobayashi, Michiya ^a   Hanazaki, Kazuhiro ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

Chemotherapy; Diamine oxidase activity; Gastric cancer; Gastrointestinal tract toxicity; Quality of life

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; ANOREXIA; ARTICLE; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; DIARRHEA; ENZYME ACTIVITY; FEMALE; GASTROINTESTINAL DISEASE; HEALTH STATUS; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; QUALITY OF LIFE; STOMACH CANCER; STOMATITIS;

ADMINISTRATION, ORAL; ADULT; AGED; AMINE OXIDASE (COPPER-CONTAINING); ANTIMETABOLITES, ANTINEOPLASTIC; FEMALE; FLUOROURACIL; GASTROINTESTINAL TRACT; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; QUALITY OF LIFE; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84858315734     PISSN: 00302414     EISSN: 14230232     Source Type: Journal    
DOI: 10.1159/000336799     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ: Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 106-130.
2. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K ACTS-GC Group: Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 2007; 357: 1810-1820. (Pubitemid 350044801)
3. Luk GD, Vaughan WP, Burke PJ, Baylin SB: Diamine oxidase as a plasma marker of rat intestinal mucosal injury and regeneration after administration of 1-beta-D-arabinofuranosylcytosine. Cancer Res 1981; 41: 2334-2337. (Pubitemid 11111438)
4. Wolvekamp MC, de Bruin RW: Diamine oxidase: an overview of historical, biochemical and functional aspects. Dig Dis 1994; 12: 2-14.
5. Biegäski T: Biochemical, physiological and pathophysiological aspects of intestinal diamine oxidase. Acta Physiol Pol 1983; 34: 139-154.
6. Luk GD, Bayless TM, Baylin SB: Diamine oxidase (histaminase). A circulating marker for rat intestinal mucosal maturation and integrity. J Clin Invest 1980; 66: 66-70. (Pubitemid 10071349)
7. Luk GD, Bayless TM, Baylin SB: Plasma postheparin diamine oxidase. Sensitive provocative test for quantitating length of acute intestinal mucosal injury in the rat. J Clin Invest 1983; 71: 1308-1315. (Pubitemid 13098918)
8. Tsujikawa T, Uda K, Ihara T, Inoue T, Andoh A, Fujiyama Y, Bamba T: Changes in serum diamine oxidase activity during chemotherapy in patients with hematological malignancies. Cancer Lett 1999; 147: 195-198.
9. Mayumi T, Takezawa J, Takahashi H, Kuwayama N, Fukuoka T, Yamada K, Nakao M, Takagi K: Evaluation of intestinal mucosal integrity using serum diamine oxidase. Dig Absorp 1997; 20: 143-148.
10. Buts JP, Theys S, De Keyser N, Dive C: Changes in serum and intestinal diamine oxidase (DAO) activity after proximal enterectomy in rats. Correlation of DAO activity with mucosal mass parameters. Dig Dis Sci 1989; 34: 1393-1398. (Pubitemid 19247396)
11. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-376. (Pubitemid 23073154)
12. Takagi K, Nakao M, Ogura Y, Nabeshima T, Kunii A: Sensitive colorimetric assay of serum diamine oxidase. Clin Chim Acta 1994; 226: 67-75. (Pubitemid 24167304)
13. Kobayashi K, Takeda F, Teramukai S, Gotoh I, Sakai H, Yoneda S, Noguchi Y, Ogasawa-ra H, Yoshida K: A cross-validation of the European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30) for Japanese with lung cancer. Eur J Cancer 1998; 34: 810-815. (Pubitemid 28248489)
14. Sobin LH, Gospodarowicz MK, Wittekind C, eds: TNM Classification of Malignant Tumours, ed 7. New York, Wiley-Blackwell, 2009.
15. Wittekind C, Greene F, Hutter RVP, Sobin LH, Henson DE (eds): TNM Supplement: a Commentary on Uniform Use, ed 3. New York, Wiley-Liss, 2003.
16. Moriyama K, Kouchi Y, Morinaga H, Irimura K, Hayashi T, Ohuchida A, Goto T, Yoshizawa Y: Diamine oxidase, a plasma biomarker in rats to GI tract toxicity of oral fluorouracil anti-cancer drugs. Toxicology 2006; 217: 233-239. (Pubitemid 41773840)
17. Usami M, Ohata A, Kishimoto K, Ohmae K, Aoyama M, Miyoshi M, Fueda Y: Phospholipid fatty acid composition and diamine oxidase activity of intestinal mucosa from rats treated with irinotecan hydrochloride (CPT-11) under vegetable oil-enriched diets: comparison between perilla oil and corn oil. JPEN J Parenter Enteral Nutr 2006; 30: 124-132. (Pubitemid 44314786)
18. Rhoads JM, Keku EO, Quinn J, Woosely J, Lecce JG: L-Glutamine stimulates jejunal sodium and chloride absorption in pig rotavirus enteritis. Gastroenterology 1991; 100: 683-691.
19. Li JY, Lu Y, Hu S, Sun D, Yao YM: Preventive effect of glutamine on intestinal barrier dysfunction induced by severe trauma. World J Gastroenterol 2002; 8: 168-171. (Pubitemid 34149784)
20. Quan ZF, Yang C, Li N, Li JS: Effect of glutamine on change in early postoperative intestinal permeability and its relation to systemic inflammatory response. World J Gastroenterol 2004; 10: 1992-1994. (Pubitemid 39029310)
21. Ishii K, Kono H, Hosomura N, Tsuchiya M, Ohgiku M, Tanaka N, Fujii H: Mediumchain triglycerides enhance mucous secretion and cell proliferation in the rat. J Gastroenterol 2009; 44: 204-211.